Subscribe To
BLTE / Why Shares of Belite Bio Soared This Week
BLTE News
By Zacks Investment Research
August 21, 2023
Belite Bio (BLTE) Stock Surges 72% in a Month: Here's Why
Belite Bio (BLTE) rises 72% in a month due to encouraging progress on the development of the company's lead product candidate Tinlarebant, which is be more_horizontal
By Seeking Alpha
August 13, 2023
Belite Bio, Inc (BLTE) Q2 2023 Earnings Call Transcript
Belite Bio, Inc (NASDAQ:BLTE ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Tom Lin - Chairman and Chief Executive more_horizontal
By The Motley Fool
June 30, 2023
Why Shares of Belite Bio Soared This Week
Investors, seeing the 52-week low, saw a bargain in Belite Bio. The company doesn't have any revenue, but it has a promising eye disease therapy. more_horizontal
By Seeking Alpha
June 15, 2023
Belite Bio: Undercovered Eye Disease Company With Early Data
BLTE works with retinal disease patients. Their lead asset has positive phase 1 data. Their cash position and trial patient population are two worries more_horizontal
By Benzinga
June 9, 2023
Top 5 Health Care Stocks That Are Set To Fly In Q2 - ClearPoint Neuro (NASDAQ:CLPT), Belite Bio (NASDAQ:BLTE)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. more_horizontal
By The Motley Fool
May 31, 2023
Why Shares of Belite Bio Are Slumping Wednesday
Belite Bio is a clinical-stage biopharmaceutical company focusing on rare eye diseases and other metabolic disorders. In the first quarter, the compan more_horizontal
By Seeking Alpha
May 14, 2023
Belite Bio, Inc (BLTE) Q1 2023 Earnings Call Transcript
Belite Bio, Inc (NASDAQ:BLTE ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Tom Lin - Chairman and Chief Executive Of more_horizontal
By GlobeNewsWire
May 10, 2023
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical stage biopharmaceutical drug development company focused on adv more_horizontal